MesenFlow Technologies

Switzerland
Hasle, Lucerne, Switzerland

Company profile

MesenFlow Technologies company profile

MesenFlow Technologies has developed a platform to meet the demands of modern drug development. It is a bio-imaging technology designed to accelerate the drug development process & provide solutions to problems associated with species cross-reactivity, animal testing & understanding human disease. This has been achieved by using proprietary protocols on primary human cells, allowing the mechanism of action & translational relevance of a drug to be defined very early on in the development process. MesenFlow Technologies has recently extended this technology for use in cosmetics and nutrition. By using their technology, it is possible to explore the physiological impact of a cosmetic or nutraceutical candidate in the early development phase. Their services are particularly tailored to business environments where animal-free testing is mandatory, and an understanding of impact on human biology is paramount.

Business identity

Phone number
41 22 32 16 961
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2016-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Last funding
Grant / $10,064 / 2017-04-25
Investors
2
Lead investors
1
Founders
2

Categories and groups

Founders and investors

Founders

Paul BradfieldRiccardo Nisato

Lead investors

Venture Kick

Investors

MassChallengeVenture Kick